已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Leadless pacemakers at 5-year follow-up: the Micra transcatheter pacing system post-approval registry

医学
作者
Mikhael F. El‐Chami,Christophe Garweg,Nicolas Clémenty,Faisal Al-Samadi,Saverio Iacopino,José Luis Martínez‐Sande,Paul Richard Roberts,Claudio Tondo,Jens Brock Johansen,Xavier Viñolas,Yong‐Mei Cha,Eric M. Grubman,Pierre Bordachar,Kurt D. Stromberg,Dedra H. Fagan,Jonathan Paul Piccini
出处
期刊:European Heart Journal [Oxford University Press]
卷期号:45 (14): 1241-1251 被引量:138
标识
DOI:10.1093/eurheartj/ehae101
摘要

BACKGROUND AND AIMS: Prior reports have demonstrated a favourable safety and efficacy profile of the Micra leadless pacemaker over mid-term follow-up; however, long-term outcomes in real-world clinical practice remain unknown. Updated performance of the Micra VR leadless pacemaker through five years from the worldwide post-approval registry (PAR) was assessed. METHODS: All Micra PAR patients undergoing implant attempts were included. Endpoints included system- or procedure-related major complications and system revision rate for any cause through 60 months post-implant. Rates were compared through 36 months post-implant to a reference dataset of 2667 transvenous pacemaker patients using Fine-Gray competing risk models. RESULTS: 1809 patients were enrolled between July 2015 and March 2018 and underwent implant attempts from 179 centres in 23 countries with a median follow-up period of 51.1 months (IQR: 21.6-64.2). The major complication rate at 60 months was 4.5% [95% confidence interval (CI): 3.6%-5.5%] and was 4.1% at 36 months, which was significantly lower than the 8.5% rate observed for transvenous systems (HR: .47, 95% CI: .36-.61; P < .001). The all-cause system revision rate at 60 months was 4.9% (95% CI: 3.9%-6.1%). System revisions among Micra patients were mostly for device upgrades (41.2%) or elevated thresholds (30.6%). There were no Micra removals due to infection noted over the duration of follow-up. At 36 months, the system revision rate was significantly lower with Micra vs. transvenous systems (3.2% vs. 6.6%, P < .001). CONCLUSIONS: Long-term outcomes with the Micra leadless pacemaker continue to demonstrate low rates of major complications and system revisions and an extremely low incidence of infection.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
canyd完成签到,获得积分10
刚刚
无私含卉发布了新的文献求助10
刚刚
刚刚
1秒前
NexusExplorer的应助被橘子采纳,获得10
1秒前
黎明完成签到,获得积分10
1秒前
帆帆发布了新的文献求助10
2秒前
infinity发布了新的文献求助10
3秒前
molihuakai的应助被huangYinghua采纳,获得10
5秒前
can858发布了新的文献求助10
5秒前
吴军霄完成签到,获得积分10
5秒前
7秒前
好久不见发布了新的文献求助10
7秒前
9秒前
玉洁松贞的应助被阿苏采纳,获得30
9秒前
9秒前
10秒前
科研通AI6.2的应助被高大橙采纳,获得10
11秒前
huifeideyu发布了新的文献求助10
11秒前
11秒前
window1000发布了新的文献求助10
11秒前
12秒前
14秒前
archon709发布了新的文献求助10
14秒前
16秒前
vc发布了新的文献求助10
16秒前
16秒前
16秒前
16秒前
小鱼发布了新的文献求助10
16秒前
18秒前
18秒前
19秒前
陈俊涛发布了新的文献求助20
20秒前
20秒前
栗子发布了新的文献求助10
21秒前
22秒前
disappear发布了新的文献求助10
23秒前
xiaohan发布了新的文献求助10
23秒前
Zinco1027发布了新的文献求助10
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179198
求助须知:如何正确求助?哪些是违规求助? 9569781
关于积分的说明 21806509
捐赠科研通 7774542
什么是DOI,文献DOI怎么找? 3433008
关于科研通互助平台的介绍 2556929
邀请新用户注册赠送积分活动 2478652